title: Amplification Target ADRM1: Role as an Oncogene and Therapeutic Target for Ovarian Cancer.
abstract: Approximately 25,000 ovarian cancers are diagnosed in the U.S. annually, and 75% are in the advanced stage and largely incurable. There is critical need for early detection tools and novel treatments. Proteasomal ubiquitin receptor ADRM1 is a protein that is encoded by the ADRM1 gene. Recently, we showed that among 20q13-amplified genes in ovarian cancer, ADRM1 overexpression was the most highly correlated with amplification and was significantly upregulated with respect to stage, recurrence, and metastasis. Its overexpression correlated significantly with shorter time to recurrence and overall survival. Array-CGH and microarray expression of ovarian cancer cell lines provided evidence consistent with primary tumor data that ADRM1 is a 20q13 amplification target. Herein, we confirm the ADRM1 amplicon in a second ovarian cancer cohort and define a minimally amplified region of 262 KB encompassing seven genes. Additionally, using RNAi knock-down of ADRM1 in naturally amplified cell line OAW42 and overexpression of ADRM1 via transfection in ES2, we show that (1) ADRM1 overexpression increases proliferation, migration, and growth in soft agar, and  (2) knock-down of ADRM1 results in apoptosis. Proteomic analysis of cells with ADRM1 knock-down reveals dysregulation of proteins including CDK-activating kinase assembly factor MAT1. Taken together, the results indicate that amplified ADRM1 is involved in cell proliferation, migration and survival in ovarian cancer cells, supporting a role as an oncogene and novel therapeutic target for ovarian cancer.
authors: Division of Hematology-Oncology, Department of Medicine, Jonsson Comprehensive Cancer Center, University of California at Los Angeles, Los Angeles, CA 90095, USA. mfejzo@mednet.ucla.edu.
authors: Marlena S
authors: MS
authors: Fejzo
authors: Lee
authors: L
authors: Anderson
authors: Erika M
authors: EM
authors: von Euw
authors: Ondrej
authors: O
authors: Kalous
authors: Nuraly K
authors: NK
authors: Avliyakulov
authors: Michael J
authors: MJ
authors: Haykinson
authors: Gottfried E
authors: GE
authors: Konecny
authors: Richard S
authors: RS
authors: Finn
authors: Dennis J
authors: DJ
authors: Slamon
references: Genes Chromosomes Cancer. 2008 Oct;47(10):873-83
references: 18615678
references: Hum Pathol. 2012 Feb;43(2):282-8
references: 21835429
references: EMBO J. 2006 Oct 4;25(19):4524-36
references: 16990800
references: Oncol Rep. 2009 Feb;21(2):531-7
references: 19148532
references: Zhonghua Yi Xue Za Zhi. 2007 Oct 16;87(38):2719-23
references: 18167254
references: Genes Chromosomes Cancer. 2011 Jun;50(6):434-41
references: 21432940
references: Cancer Res. 2007 Jun 1;67(11):5275-84
references: 17545607
references: Clin Exp Metastasis. 1999;17(8):641-8
references: 10919708
references: Cancer Res. 2002 May 15;62(10):2923-8
references: 12019173
references: Int J Oncol. 2012 Nov;41(5):1662-8
references: 22941445
references: Adv Exp Med Biol. 2008;617:359-66
references: 18497059
references: Cell Cycle. 2005 Apr;4(4):572-7
references: 15876871
references: Endocr Relat Cancer. 2009 Dec;16(4):1229-39
references: 19675076
references: J Immunol. 1997 Mar 15;158(6):2736-44
references: 9058808
references: Pharmacogenomics J. 2006 May-Jun;6(3):189-93
references: 16402077
references: Acta Pharmacol Sin. 2007 Sep;28(9):1325-30
references: 17723166
references: FEBS J. 2005 Apr;272(8):1833-44
references: 15819879
references: Zhonghua Zhong Liu Za Zhi. 2009 Nov;31(11):815-9
references: 20137344
references: PLoS One. 2010 Oct 27;5(10):e13654
references: 21048919
references: J Biol Chem. 2009 Oct 30;284(44):30159-66
references: 19740742
references: Mol Cancer. 2011 Sep 30;10:125
references: 21962244
references: Neoplasia. 2004 Nov-Dec;6(6):744-50
references: 15720800
references: Mol Biol Cell. 2006 Dec;17(12):4982-7
references: 16987957
references: Circ Res. 2006 Aug 18;99(4):415-23
references: 16857965
references: EMBO J. 2006 Dec 13;25(24):5742-53
references: 17139257
references: J Biol Chem. 2004 Nov 19;279(47):49406-13
references: 15339924
references: Proteomics. 2007 Nov;7(21):3906-18
references: 17922515